SonoTarg Current Stage of Development
At SonoTarg we are welcoming the new year with the launch of our 2 minute animation video at the end of this week
SonoTarg is now preparing to conduct its first clinical trial, this will be a Phase 1 trial of our lead product ST001 and will involve a small number of patients with cancer.
The primary aim of the study will be to show that ST001 can be given safely to cancer patients.
Before we can start we need to manufacture the product then obtain the necessary approvals to begin the clinical trial, we anticipate that these approvals will be in place by mid 2025 and that we will be able to begin the trial shortly thereafter.
Follow our LinkedIn to keep up to date with our developments and be the first to see our animation video on Thursday 16th January.